nuclear receptor coactivator 6; amplified in breast cancer protein 3; cancer-amplified transcriptional coactivator ASC-2; activating signal cointegrator 2; ASC-2; peroxisome proliferator-activated receptor-interacting protein; PPAR-interacting protein; PRIP; nuclear receptor-activating protein, 250 kDa; nuclear receptor coactivator RAP250; NRC RAP250; thyroid hormone receptor-binding protein (NCOA6, AIB3, KIAA0181, RAP250, TRBP)
Jump to navigation
Jump to search
Function
- directly binds nuclear receptors & stimulates hormone-dependent transcriptional activity
- steroids (glucocorticoid receptor, estrogen receptor),
- retinoids (RAR, RXR)
- thyroid hormone receptor
- vitamin D3 receptor
- PPAR
- general coactivator, NOT ONLY nuclear receptor coactivator
- coactivation of the NF-kappa-B pathway
- remodeling of chromatin
- interaction with histone acetyltransferase
- interacts with RNPC2, GTF2A, TBP, NCOA1, CRSP3, RBM14, EP300, CREBBP, NCOA6IP, PRMT2/HRMT1L1
- phosphorylated by PRKDC
- phosphorylation on Ser884 decreases binding to ESR1, ESR2
- component of: ASC2/NCOA6 complex (ASCOM)
Structure
- monomer, homodimer
- contains two Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs
- only motif 1 is essential for the association with nuclear receptors, while adjacent Ser-884 displays selectivity for nuclear receptors
Compartment
Expression
- ubiquitous
- highly expressed in brain, prostate, testis, ovary
- weakly expressed in lung, thymus, small intestine
Pathology
- frequently amplified or ovexpressed in colon cancer, breast cancer, lung cancers